Delivered total first quarter revenue of $707 million, an increase of 11% on a reported and core revenue basis, including Screening revenue of ...
First quarter revenue was $10.36 billion. First quarter GAAP diluted earnings per share (EPS) grew 15% to $3.98. First quarter adjusted EPS gre...
Actum Pharma (Actum), a strategy and operating business partner to global biopharma manufacturers, today announces two executive appointments to launch a...
Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjug...
Enhancing high-quality logistics operations across the Americas, Asia Pacific, and EMEA to meet the evolving needs of the life sciences and healthcare ...
iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, announced the acquisition of ...
Octapharma celebrates a historic milestone as NHS patients begin receiving medicines made from UK-donated plasma for the first time in nearly three decad...
Key Financial Highlights: Full-year net sales increased to €21.2 billion (organically: +2.0%) EBITDA pre rose to €6.1 billion (orga...
The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...
The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed ...
Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated a cutting-edge Cell & Gene Therapy Center in Genome Valley...
Philadelphia has long been known as a hub for history, education, and culture. But in recent years, the city has also solidified itself as a powerhouse i...
Appointment of three internal senior executives ensures strategic continuity with a new era of leadership Jean-Charles Wirth to become CEO Life Scienc...
Artificial intelligence is reshaping oncology, and ImpriMed is at the forefront of this transformation. With its AI-powered Personalized Prediction Profi...
© 2025 Biopharma Boardroom. All Rights Reserved.
